CHE - Chemed Corp.About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $446.35 | Open | $448.80 |
| Volume | 177.9K | Market Cap | 7.126B |
| Yield | 0.30 % | Last Dividend | $1.32 |
| Chemed Reports Fourth-Quarter 2020 Resul... | 02/23/21 |
| CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation???s large... | |
| Chemed Does Earnings Surprise History Ho... | 02/22/21 |
| Chemed announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| Chemed To Report Fourth-Quarter 2020 Ear... | 02/03/21 |
| CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended Decembe... | |
| Year-on-year output expansion reported b... | 01/15/21 |
| Latest results from Cherkizovo Group of Russia reveal increased production volumes by almost all its businesses in 2020. | |
| 'Halftime Report' Final Trades: CVS Heal... | 01/08/21 |
| On CNBC's "Fast Money Halftime Report," the investment committee gave their final trades. Decatur Capital Management CEO Degas Wright likes Chemed Cor... | |
| What Did Chemed???s (NYSE:CHE) CEO Take ... | 12/11/20 |
| What Did Chemed's (NYSE:CHE) CEO Take Home Final 12 months? - | |
| At-Need Death Care Market 2020 Demand an... | 11/10/20 |
| This report is an extensive analysis of current and potential trends in the At-Need Death Care market. The report provides an in-depth quantitative an... | |
| FXNEWS24 |Is Chemed (CHE) a Solid Growth... | 11/04/20 |
| Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think " Yes " | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News | |
| RBC Capital Stick to Their Buy Rating fo... | 11/03/20 |
| RBC Capital Stick to Their Buy Rating for Chemed Corporation | |
| Chemed To Report Third-Quarter 2020 Earn... | 10/12/20 |
| CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended Septembe... | |
| Home Care Providers Market (COVID-19 Imp... | 10/12/20 |
| The HOME CARE PROVIDERS Market report makes available a thoughtful overview of product specification, technology, product type and production analysis... | |
| A $2 billion fund manager says market vo... | 10/12/20 |
| Summary List Placement With the election approaching, uncertainty lingering around the timing and scale of additional fiscal stimulus, and a potential... | |
| Death Care Market Size, Key Trends, Chal... | 09/30/20 |
| Los Angeles, United State, ??? ??? QY Research recently added a research report, Global Death Care Market Research Report 2020 to its ever-increasing ... | |
| Chemed Corporation Declares Quarterly Di... | 08/06/20 |
| CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 34-ce... | |
| Chemed Reports Second-Quarter 2020 Resul... | 07/29/20 |
| CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation???s large... | |
| Chemed Q2 2020 Earnings Preview (NYSE:CH... | 07/28/20 |
| Chemed (NYSE:CHE) is scheduled to announce Q2 earnings results on Wednesday, July 29th, after market close. The consensus EPS Estimate is $3.75 (+11.6... | |
| Chemed To Report Second-Quarter 2020 Ear... | 07/08/20 |
| CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30... | |
| Chemed (CHE) Outpaces Stock Market Gains... | 06/25/20 |
| Chemed (CHE) closed the most recent trading day at $450, moving +1.12% from the previous trading session. | |
| Chemed (CHE) Stock Sinks As Market Gains... | 05/29/20 |
| Chemed (CHE) closed at $478.51 in the latest trading session, marking a -0.78% move from the prior day. | |
| Why Is Chemed (CHE) Up 8.3% Since Last E... | 05/28/20 |
| Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Here's Why You Should Hold on to Chemed ... | 05/28/20 |
| Investors continue to be optimistic about Chemed (CHE) on robust segmental growth. | |
| Chemed Corporation to Present at the Jef... | 05/27/20 |
| CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2020 Virtual Healthcar... | |
| The Zacks Analyst Blog Highlights: Brook... | 05/27/20 |
| The Zacks Analyst Blog Highlights: Brookdale Senior Living, The Ensign Group, Amedysis and Chemed | |
| Chemed Corporation Holds Annual Meeting ... | 05/18/20 |
| CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company???s 2020 annual stockh... | |
| What Makes Chemed (CHE) a New Buy Stock | 05/14/20 |
| Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). | |
| Chemed Corporation to Present at the Bof... | 05/05/20 |
| CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2020 Virtual Health Care Confer... | |
| Chemed's (CHE) Q1 Earnings Beat Estimate... | 04/29/20 |
| Chemed's (CHE) first-quarter 2020 results reflect strong segmental performances amid the coronavirus-led economic doldrums. | |
| Chemed (CHE) Q1 Earnings Surpass Estimat... | 04/28/20 |
| Chemed (CHE) delivered earnings and revenue surprises of 2.22% and -1.49%, respectively, for the quarter ended March 2020. Do the numbers hold clues t... | |
| Chemed Reports First-Quarter 2020 Result... | 04/28/20 |
| CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation???s large... | |
| Why Chemed (CHE) Might Surprise This Ear... | 04/27/20 |
| Chemed (CHE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. | |
| Strong Buy rating | 02/25/21 |
| Oppenheimer maintains Outperform rating and lowers Price Target from $600.00 to $580.00 | |
| Date | 2021-02-23 (AMC) | Est. (EPS/Rev.) | $5.13/ 537.2M |
| Actual (EPS/Rev.) | $5.13/ $533.29 M | EPS (TTM) | 14.46 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
